By Canntab Therapeutics Ltd on Friday, 31 May 2019
Category: Pharmaceutical - BioTech

Canntab Therapeutics and Heritage Cannabis strike deal to work together

viewCanntab Therapeutics Ltd

() President and CEO Clint Sharples and Canntab Therapeutics () CFO Richard Goldstein joined Christine Corrado from Proactive Investors New York to talk about their partnership that seems to really benefit both companies.

Heritage’s subsidiary Purefarma Solutions will provide processing services for hemp supplied by Canntab, to their specification as required for the production of Canntab’s planned ingestible oral cannabis products. The partnership will start right away. 

CSE:PILL

Market: CSE
Market Cap: $12.15 m
Follow

View company profile

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Canntab Therapeutics Ltd named herein, including the promotion by the Company of Canntab Therapeutics Ltd in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Most read

Full interview: Exactus clinches two supply agreements

Exactus Inc (OTCMKTS:EXDI) CEO Emiliano Aloi tells Proactive it has entered into a supply and distribution agreement with Ceed2Med, as well as supplying hemp to Canntab Therapeutics Limited (CSE:PILL) (OTCMKTS:CTABF). Aloi says its an exciting venture and expects to push its products with...

on 11/26/2019

2 min read

Related Posts